Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions

Journal of Virology

Volumn 90, Issue 16, 2016, Pages 7268-7284

  Nelson, Emily V ^a,b   Schmidt, Kristina M ^a,b,g   Deflubé, Laure R ^a,b   Doĝanay, Sultan ^c   Banadyga, Logan ^d   Olejnik, Judith ^a,b   Hume, Adam J ^a,b   Ryabchikova, Elena ^e   Ebihara, Hideki ^d   Kedersha, Nancy ^f   Ha, Taekjip ^c   Muhlberger, Elke ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c University of Illinois at Urbana Champaign   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENITE SODIUM; CELL PROTEIN; INITIATION FACTOR; STRESS GRANULE PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; HEAT SHOCK PROTEIN; IMMUNOLOGIC FACTOR; VIRAL PROTEIN; VP35 PROTEIN, FILOVIRUS;

ANIMAL CELL; ARTICLE; CELL STRESS; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; FILOVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RNA TRANSLATION; STRESS GRANULE; VIRUS INCLUSION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; ZAIRE EBOLAVIRUS; ANIMAL; CELL GRANULE; CELL LINE; CHEMISTRY; CYTOPLASM; EBOLAVIRUS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGICAL STRESS; VIROLOGY;

ANIMALS; CELL LINE; CYTOPLASM; CYTOPLASMIC GRANULES; EBOLAVIRUS; HEAT-SHOCK PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOLOGIC FACTORS; INCLUSION BODIES, VIRAL; STRESS, PHYSIOLOGICAL; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84977067403     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00459-16     Document Type: Article

References (83)

1. Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet 377:849-862. http://dx.doi.org/10.1016/S0140-6736(10)60667-8.
2. Messaoudi I, Amarasinghe GK, Basler CF. 2015. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat Rev Microbiol 13:663-676. http://dx.doi.org/10.1038/nrmicro3524.
3. Mühlberger E. 2007. Filovirus replication and transcription. Future Virol 2:205-215. http://dx.doi.org/10.2217/17460794.2.2.205.
4. Brauburger K, Deflubé LR, Mühlberger E. 2015. Filovirus transcription and replication, p 515-555. In Pattnaik AK, Whitt MA (ed), Biology and pathogenesis of rhabdo-and filoviruses. World Scientific Publishing Co Pte Ltd, Singapore.
5. Mühlberger E, Weik M, Volchkov VE, Klenk H-D, Becker S. 1999. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol 73: 2333-2342.
6. Huang Y, Xu L, Sun Y, Nabel GJ. 2002. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell 10:307-316. http://dx.doi.org/10.1016/S1097-2765(02)00588-9.
7. Noda T, Aoyama K, Sagara H, Kida H, Kawaoka Y. 2005. Nucleocapsidlike structures of Ebola virus reconstructed using electron tomography. J Vet Med Sci 67:325-328. http://dx.doi.org/10.1292/jvms.67.325.
8. Bharat TA, Noda T, Riches JD, Kraehling V, Kolesnikova L, Becker S, Kawaoka Y, Briggs JA. 2012. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc Natl Acad Sci U S A 109:4275-4280. http://dx.doi.org/10.1073/pnas.1120453109.
9. Watt A, Moukambi F, Banadyga L, Groseth A, Callison J, Herwig A, Ebihara H, Feldmann H, Hoenen T. 2014. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J Virol 88:10511-10524. http://dx.doi.org/10.1128/JVI.01272-14.
10. Hoenen T, Shabman RS, Groseth A, Herwig A, Weber M, Schudt G, Dolnik O, Basler CF, Becker S, Feldmann H. 2012. Inclusion bodies are a site of ebolavirus replication. J Virol 86:11779-11788. http://dx.doi.org/10.1128/JVI.01525-12.
11. Nanbo A, Watanabe S, Halfmann P, Kawaoka Y. 2013. The spatiotemporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Sci Rep 3:1206.
12. Schudt G, Dolnik O, Kolesnikova L, Biedenkopf N, Herwig A, Becker S. 2015. Transport of Ebolavirus nucleocapsids is dependent on actin polymerization: live-cell imaging analysis of Ebolavirus-infected cells. J Infect Dis 212(Suppl 2):S160-S166.
13. Dolnik O, Kolesnikova L, Stevermann L, Becker S. 2010. Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles. J Virol 84:7847-7856. http://dx.doi.org/10.1128/JVI.00476-10.
14. Ryabchikova E, Price BBS. 2004. Ebola and Marburg viruses: a view of infection using electron microscopy. Battelle Press, Columbus, OH.
15. Noda T, Ebihara H, Muramoto Y, Fujii K, Takada A, Sagara H, Kim JH, Kida H, Feldmann H, Kawaoka Y. 2006. Assembly and budding of Ebolavirus. PLoS Pathog 2:e99. http://dx.doi.org/10.1371/journal.ppat.0020099.
16. Olejnik J, Ryabchikova E, Corley RB, Mühlberger E. 2011. Intracellular events and cell fate in filovirus infection. Viruses 3:1501-1531. http://dx.doi.org/10.3390/v3081501.
17. Anderson P, Kedersha N. 2009. Stress granules. Curr Biol 19:R397-R398. http://dx.doi.org/10.1016/j.cub.2009.03.013.
18. McAllister CS, Taghavi N, Samuel CE. 2012. Protein kinase PKR amplification of interferon beta induction occurs through initiation factor eIF-2alpha-mediated translational control. J Biol Chem 287:36384-36392. http://dx.doi.org/10.1074/jbc.M112.390039.
19. Onomoto K, Jogi M, Yoo JS, Narita R, Morimoto S, Takemura A, Sambhara S, Kawaguchi A, Osari S, Nagata K, Matsumiya T, Namiki H, Yoneyama M, Fujita T. 2012. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 7:e43031. http://dx.doi.org/10.1371/journal.pone.0043031.
20. Onomoto K, Yoneyama M, Fung G, Kato H, Fujita T. 2014. Antiviral innate immunity and stress granule responses. Trends Immunol 35:420-428. http://dx.doi.org/10.1016/j.it.2014.07.006.
21. Anderson P, Kedersha N. 2008. Stress granules: the Tao of RNA triage. Trends Biochem Sci 33:141-150. http://dx.doi.org/10.1016/j.tibs.2007.12.003.
22. Anderson P, Kedersha N. 2009. RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat Rev Mol Cell Biol 10:430-436. http://dx.doi.org/10.1038/nrm2694.
23. Kedersha N, Anderson P. 2009. Regulation of translation by stress granules and processing bodies. Prog Mol Biol Transl Sci 90:155-185. http://dx.doi.org/10.1016/S1877-1173(09)90004-7.
24. Buchan JR, Parker R. 2009. Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36:932-941. http://dx.doi.org/10.1016/j.molcel.2009.11.020.
25. Kedersha N, Cho MR, Li W, Yacono PW, Chen S, Gilks N, Golan DE, Anderson P. 2000. Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol 151:1257-1268. http://dx.doi.org/10.1083/jcb.151.6.1257.
26. Anderson P, Kedersha N, Ivanov P. 2015. Stress granules, P-bodies and cancer. Biochim Biophys Acta 1849:861-870. http://dx.doi.org/10.1016/j.bbagrm.2014.11.009.
27. Montero H, Trujillo-Alonso V. 2011. Stress granules in the viral replication cycle. Viruses 3:2328-2338. http://dx.doi.org/10.3390/v3112328.
28. White JP, Lloyd RE. 2012. Regulation of stress granules in virus systems. Trends Microbiol 20:175-183. http://dx.doi.org/10.1016/j.tim.2012.02.001.
29. Beckham CJ, Parker R. 2008. P bodies, stress granules, and viral life cycles. Cell Host Microbe 3:206-212. http://dx.doi.org/10.1016/j.chom.2008.03.004.
30. Matthews JD, Frey TK. 2012. Analysis of subcellular G3BP redistribution during rubella virus infection. J Gen Virol 93:267-274. http://dx.doi.org/10.1099/vir.0.036780-0.
31. Panas MD, Varjak M, Lulla A, Eng Merits KEA, Karlsson Hedestam GB, McInerney GM. 2012. Sequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infection. Mol Biol Cell 23:4701-4712. http://dx.doi.org/10.1091/mbc.E12-08-0619.
32. White JP, Lloyd RE. 2011. Poliovirus unlinks TIA1 aggregation and mRNA stress granule formation. J Virol 85:12442-12454. http://dx.doi.org/10.1128/JVI.05888-11.
33. Scholte FE, Tas A, Albulescu IC, Zusinaite E, Merits A, Snijder EJ, van Hemert MJ. 2015. Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication. J Virol 89:4457-4469. http://dx.doi.org/10.1128/JVI.03612-14.
34. Elde NC, Child SJ, Geballe AP, Malik HS. 2009. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457:485-489. http://dx.doi.org/10.1038/nature07529.
35. Dauber B, Wolff T. 2009. Activation of the antiviral kinase PKR and viral countermeasures. Viruses 1:523-544. http://dx.doi.org/10.3390/v1030523.
36. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, Garcia-Sastre A. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77:7945-7956. http://dx.doi.org/10.1128/JVI.77.14.7945-7956.2003.
37. Hartman AL, Towner JS, Nichol ST. 2004. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology 328: 177-184. http://dx.doi.org/10.1016/j.virol.2004.07.006.
38. Cárdenas WB, Loo YM, Gale M, Jr, Hartman AL, Kimberlin CR, Martinez-Sobrido L, Saphire EO, Basler CF. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 80:5168-5178. http://dx.doi.org/10.1128/JVI.02199-05.
39. Hartman AL, Bird BH, Towner JS, Antoniadou ZA, Zaki SR, Nichol ST. 2008. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. J Virol 82:2699-2704. http://dx.doi.org/10.1128/JVI.02344-07.
40. Prins KC, Cardenas WB, Basler CF. 2009. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol 83:3069-3077. http://dx.doi.org/10.1128/JVI.01875-08.
41. Leung DW, Prins KC, Borek DM, Farahbakhsh M, Tufariello JM, Ramanan P, Nix JC, Helgeson LA, Otwinowski Z, Honzatko RB, Basler CF, Amarasinghe GK. 2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol 17:165-172. http://dx.doi.org/10.1038/nsmb.1765.
42. Kimberlin CR, Bornholdt ZA, Li S, Woods VL, Jr, MacRae IJ, Saphire EO. 2010. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A 107:314-319. http://dx.doi.org/10.1073/pnas.0910547107.
43. Chang TH, Kubota T, Matsuoka M, Jones S, Bradfute SB, Bray M, Ozato K. 2009. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog 5:e1000493. http://dx.doi.org/10.1371/journal.ppat.1000493.
44. Leung LW, Park MS, Martinez O, Valmas C, Lopez CB, Basler CF. 2011. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells. Immunol Cell Biol 89:792-802. http://dx.doi.org/10.1038/icb.2010.169.
45. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, Berkhout B. 2007. The Ebola virus VP35 protein is a suppressor ofRNAsilencing. PLoS Pathog 3:e86. http://dx.doi.org/10.1371/journal.ppat.0030086.
46. Fabozzi G, Nabel CS, Dolan MA, Sullivan NJ. 2011. Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J Virol 85:2512-2523. http://dx.doi.org/10.1128/JVI.01160-10.
47. Feng Z, Cerveny M, Yan Z, He B. 2007. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol 81:182-192. http://dx.doi.org/10.1128/JVI.01006-06.
48. Schümann M, Gantke T, Mühlberger E. 2009. Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol 83:8993-8997. http://dx.doi.org/10.1128/JVI.00523-09.
49. Olejnik J, Alonso J, Schmidt KM, Yan Z, Wang W, Marzi A, Ebihara H, Yang J, Patterson JL, Ryabchikova E, Mühlberger E. 2013. Ebola virus does not block apoptotic signaling pathways. J Virol 87:5384-5396. http://dx.doi.org/10.1128/JVI.01461-12.
50. White JP, Cardenas AM, Marissen WE, Lloyd RE. 2007. Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe 2:295-305. http://dx.doi.org/10.1016/j.chom.2007.08.006.
51. Kedersha N, Tisdale S, Hickman T, Anderson P. 2008. Real-time and quantitative imaging of mammalian stress granules and processing bodies. Methods Enzymol 448:521-552. http://dx.doi.org/10.1016/S0076-6879 (08)02626-8.
52. Kedersha N, Panas MD, Achorn CA, Lyons S, Tisdale S, Hickman T, Thomas M, Lieberman J, McInerney GM, Ivanov P, Anderson P. 2016. G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits. J Cell Biol 212:845-860. http://dx.doi.org/10.1083/jcb.201508028.
53. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193-199. http://dx.doi.org/10.1016/0378-1119(91)90434-D.
54. Valmas C, Grosch MN, Schümann M, Olejnik J, Martinez O, Best SM, Krähling V, Basler CF, Mühlberger E. 2010. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog 6:e1000721. http://dx.doi.org/10.1371/journal.ppat.1000721.
55. Boehmann Y, Enterlein S, Randolf A, Mühlberger E. 2005. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. Virology 332:406-417. http://dx.doi.org/10.1016/j.virol.2004.11.018.
56. Kedersha N, Anderson P. 2002. Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans 30:963-969. http://dx.doi.org/10.1042/bst0300963.
57. Shabman RS, Jabado OJ, Mire CE, Stockwell TB, Edwards M, Mahajan M, Geisbert TW, Basler CF. 2014. Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells. mBio 5:e02011-14. http://dx.doi.org/10.1128/mBio.02011-14.
58. Weik M, Enterlein S, Schlenz K, Mühlberger E. 2005. The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J Virol 79:10660-10671. http://dx.doi.org/10.1128/JVI.79.16.10660-10671.2005.
59. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, Anderson P. 2004. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 23:1313-1324. http://dx.doi.org/10.1038/sj.emboj.7600163.
60. Dinh PX, Beura LK, Das PB, Panda D, Das A, Pattnaik AK. 2013. Induction of stress granule-like structures in vesicular stomatitis virusinfected cells. J Virol 87:372-383. http://dx.doi.org/10.1128/JVI.02305 -12.
61. Rozelle DK, Filone CM, Kedersha N, Connor JH. 2014. Activation of stress response pathways promotes formation of antiviral granules and restricts virus replication. Mol Cell Biol 34:2003-2016. http://dx.doi.org/10.1128/MCB.01630-13.
62. Simpson-Holley M, Kedersha N, Dower K, Rubins KH, Anderson P, Hensley LE, Connor JH. 2011. Formation of antiviral cytoplasmic granules during orthopoxvirus infection. J Virol 85:1581-1593. http://dx.doi.org/10.1128/JVI.02247-10.
63. Panas MD, Schulte T, Thaa B, Sandalova T, Kedersha N, Achour A, McInerney GM. 2015. Viral and cellular proteins containing FGDF motifs bind G3BP to block stress granule formation. PLoS Pathog 11:e1004659. http://dx.doi.org/10.1371/journal.ppat.1004659.
64. Lloyd RE. 2013. Regulation of stress granules and P-bodies during RNA virus infection. Wiley Interdiscip Rev RNA 4:317-331. http://dx.doi.org/10.1002/wrna.1162.
65. Bordeleau ME, Mori A, Oberer M, Lindqvist L, Chard LS, Higa T, Belsham GJ, Wagner G, Tanaka J, Pelletier J. 2006. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat Chem Biol 2:213-220. http://dx.doi.org/10.1038/nchembio776.
66. Savinova O, Jagus R. 1997. Use of vertical slab isoelectric focusing and immunoblotting to evaluate steady-state phosphorylation of eIF2 alpha in cultured cells. Methods 11:419 -425. http://dx.doi.org/10.1006/meth.1996.0438.
67. Trunschke M, Conrad D, Enterlein S, Olejnik J, Brauburger K, Mühlberger E. 2013. The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals. Virology 441:135-145. http://dx.doi.org/10.1016/j.virol.2013.03.013.
68. Noda T, Kolesnikova L, Becker S, Kawaoka Y. 2011. The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation. J Infect Dis 204(Suppl 3):S878-S883.
69. Lu L, Han AP, Chen JJ. 2001. Translation initiation control by hemeregulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses. Mol Cell Biol 21:7971-7980. http://dx.doi.org/10.1128/MCB.21.23.7971-7980.2001.
70. McEwen E, Kedersha N, Song B, Scheuner D, Gilks N, Han A, Chen JJ, Anderson P, Kaufman RJ. 2005. Heme-regulated inhibitor kinasemediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. J Biol Chem 280:16925-16933. http://dx.doi.org/10.1074/jbc.M412882200.
71. Ivanova AA, Velichko AK, Kantidze OL, Razin SV. 2015. Heat stress induces formation of cytoplasmic granules containing HSC70 protein. Dokl Biochem Biophys 463:213-215. http://dx.doi.org/10.1134/S1607672915040043.
72. Shabman RS, Hoenen T, Groseth A, Jabado O, Binning JM, Amarasinghe GK, Feldmann H, Basler CF. 2013. An upstream open reading frame modulates ebola virus polymerase translation and virus replication. PLoS Pathog 9:e1003147. http://dx.doi.org/10.1371/journal.ppat.1003147.
73. Khaperskyy DA, Emara MM, Johnston BP, Anderson P, Hatchette TF, McCormick C. 2014. Influenza a virus host shutoff disables antiviral stress-induced translation arrest. PLoS Pathog 10:e1004217. http://dx.doi.org/10.1371/journal.ppat.1004217.
74. Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE, Stone KL, Leung L, Hensley L, Amarasinghe GK, Basler CF. 2011. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function. J Infect Dis 204(Suppl 3):S911-S918.
75. Pichlmair A, Kandasamy K, Alvisi G, Mulhern O, Sacco R, Habjan M, Binder M, Stefanovic A, Eberle CA, Goncalves A, Burckstummer T, Muller AC, Fauster A, Holze C, Lindsten K, Goodbourn S, Kochs G, Weber F, Bartenschlager R, Bowie AG, Bennett KL, Colinge J, Superti-Furga G. 2012. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature 487:486-490. http://dx.doi.org/10.1038/nature11289.
76. Shi W, Huang Y, Sutton-Smith M, Tissot B, Panico M, Morris HR, Dell A, Haslam SM, Boyington J, Graham BS, Yang ZY, Nabel GJ. 2008. A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions. J Virol 82:6190-6199. http://dx.doi.org/10.1128/JVI.02731-07.
77. Leung DW, Borek D, Luthra P, Binning JM, Anantpadma M, Liu G, Harvey IB, Su Z, Endlich-Frazier A, Pan J, Shabman RS, Chiu W, Davey RA, Otwinowski Z, Basler CF, Amarasinghe GK. 2015. An intrinsically disordered peptide from Ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein-RNA interactions. Cell Rep 11:376-389. http://dx.doi.org/10.1016/j.celrep.2015.03.034.
78. Kirchdoerfer RN, Abelson DM, Li S, Wood MR, Saphire EO. 2015. Assembly of the Ebola virus nucleoprotein from a chaperoned VP35 complex. Cell Rep 12:140 -149. http://dx.doi.org/10.1016/j.celrep.2015.06.003.
79. Fros JJ, Domeradzka NE, Baggen J, Geertsema C, Flipse J, Vlak JM, Pijlman GP. 2012. Chikungunya virus nsP3 blocks stress granule assembly by recruitment of G3BP into cytoplasmic foci. J Virol 86:10873-10879. http://dx.doi.org/10.1128/JVI.01506-12.
80. Dolnik O, Stevermann L, Kolesnikova L, Becker S. 2015. Marburg virus inclusions: a virus-induced microcompartment and interface to multivesicular bodies and the late endosomal compartment. Eur J Cell Biol 94: 323-331. http://dx.doi.org/10.1016/j.ejcb.2015.05.006.
81. Lindquist ME, Lifland AW, Utley TJ, Santangelo PJ, Crowe JE, Jr. 2010. Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol 84:12274-12284. http://dx.doi.org/10.1128/JVI.00260-10.
82. Lifland AW, Jung J, Alonas E, Zurla C, Crowe JE, Jr, Santangelo PJ. 2012. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol 86:8245-8258. http://dx.doi.org/10.1128/JVI.00215-12.
83. Fricke J, Koo LY, Brown CR, Collins PL. 2013. p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly. J Virol 87:1333-1347. http://dx.doi.org/10.1128/JVI.02263-12.